14 pharmaceutical patents will soon lapse
By the end of 2017, 14 pharmaceutical (i.e. Cialis, main Viagra's competiror) patents will soon lapse. This means that similar generic drugs could also be found on the market, resulting in a large reduction in health spending.
In 2016 the patent on the anti-cancer molecule Imatinib expired. As long as the patent was active the cost of a single pill was 15 euros. One-month therapy costed of 1800 euros. Thanks to the release of the generic drug in March 2017, healthcare expenses have dropped drastically.